Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -3.19% is 358% below its 5-year average of 1.24%, near the low end of its 5-year range (-5.79%–11.05%).
As of the fiscal period ended Tuesday, September 30, 2025. 43.05% below its 12-month average of -2.23%.
Annual fiscal-year return on invested capital; no daily interpolation. Historical series through 2025-09-30.
RETURN ON INVESTED CAPITAL (ROIC)
-3.19%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-2.23%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-1.75%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
1.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-43.05%
CURRENT VS 3Y AVG
-81.77%
CURRENT VS 5Y AVG
-357.95%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.56%
median of 500 covered companies
CURRENT VS SECTOR MEDIAN
+88.83%
vs the sector median at left
BGM Group Ltd.
Market Cap
$117.87M
Return on Invested Capital (ROIC)
-3.19%
TTM Avg
-2.23%
3Y Avg
-1.75%
5Y Avg
1.24%
Market Cap
$118.42M
Return on Invested Capital (ROIC)
-87.72%
TTM Avg
-74.88%
3Y Avg
-52.32%
5Y Avg
-62.32%
Market Cap
$115.67M
Return on Invested Capital (ROIC)
-44.81%
TTM Avg
-53.33%
3Y Avg
-46.90%
5Y Avg
-39.65%
Market Cap
$117.48M
Return on Invested Capital (ROIC)
-192.18%
TTM Avg
-186.03%
3Y Avg
-161.77%
5Y Avg
-220.86%
Market Cap
$115.44M
Return on Invested Capital (ROIC)
-97.99%
TTM Avg
-45.11%
3Y Avg
-60.38%
5Y Avg
-60.38%
Market Cap
$120.80M
Return on Invested Capital (ROIC)
-223.06%
TTM Avg
-221.51%
3Y Avg
-125.15%
5Y Avg
-99.68%
Market Cap
$122.20M
Return on Invested Capital (ROIC)
-137.40%
TTM Avg
-133.78%
3Y Avg
-372.93%
5Y Avg
-315.43%
Market Cap
$114.35M
Return on Invested Capital (ROIC)
-0.05%
TTM Avg
-44.27%
3Y Avg
-81.25%
5Y Avg
-78.53%
Market Cap
$112.88M
Return on Invested Capital (ROIC)
-61.84%
TTM Avg
-30.30%
3Y Avg
-57.06%
5Y Avg
-116.42%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BGM Group Ltd. (BGM) | $117.87M | -3.19% | -2.23% | -1.75% | 1.24% |
| Caribou Biosciences, Inc. (CRBU)vs › | $118.42M | -87.72% | -74.88% | -52.32% | -62.32% |
| Foghorn Therapeutics Inc. (FHTX)vs › | $115.67M | -44.81% | -53.33% | -46.90% | -39.65% |
| Genelux Corporation (GNLX)vs › | $117.48M | -192.18% | -186.03% | -161.77% | -220.86% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $115.44M | -97.99% | -45.11% | -60.38% | -60.38% |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $120.80M | -223.06% | -221.51% | -125.15% | -99.68% |
| TuHURA Biosciences, Inc. (HURA)vs › | $122.20M | -137.40% | -133.78% | -372.93% | -315.43% |
| Coya Therapeutics, Inc. (COYA)vs › | $114.35M | -0.05% | -44.27% | -81.25% | -78.53% |
| LENZ Therapeutics, Inc. (LENZ)vs › | $112.88M | -61.84% | -30.30% | -57.06% | -116.42% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $112.02M | -47.54% | -30.79% | -47.42% | -44.72% |
ROIC
-3.2%
ROE
-5.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-09-30 | -3.19% |
| 2024-09-30 | -1.27% |
| 2023-09-30 | -5.79% |
| 2022-09-30 | 3.23% |
| 2021-09-30 | 3.39% |
| 2020-09-30 | 11.05% |
| 2019-09-30 | 18.44% |
| 2018-09-30 | 21.72% |
| 2017-09-30 | 4.18% |
